SCHEDULE 13G: SCHEDULE 13G – Description Post author:andrewkaretas Post published:July 16, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G: SCHEDULE 13G – Description
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:June 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:June 12, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
